CN Patent

CN103945842A — 治疗肺内感染的方法

Assigned to Carrick Sa Therapeutics Inc · Expires 2014-07-23 · 12y expired

What this patent protects

本公开涉及用含有头孢菌素噻呋特啰嗪(ceftolozane)的药物组合物治疗肺内细菌感染，包括治疗医源性肺炎肺部感染。

USPTO Abstract

本公开涉及用含有头孢菌素噻呋特啰嗪(ceftolozane)的药物组合物治疗肺内细菌感染，包括治疗医源性肺炎肺部感染。

Drugs covered by this patent

Patent Metadata

Patent number: CN103945842A
Jurisdiction: CN
Classification: —
Expires: 2014-07-23
Drug substance claim: No
Drug product claim: No
Assignee: Carrick Sa Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.